The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer.
The U.S. Food and Drug Administration has approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq which was approved last Wednesday, is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or injected) or
The Food and Drugs Authority (FDA) on Wednesday said it has not given any market authorisation for any medicine for the cure of HIV and AIDS. A statement signed by Mr Hudu Mogtari, Chief Executive Officer of the FDA, said “It has come to the attention of the Food and Drugs Authority (FDA), speculations in